Dalekos G et al. Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. (Abstract GS-02)
Fecestransplantatie bij ‘C. difficile’ mogelijk met orale capsules
dec 2017 | Bacteriële infecties